Dollar losses (1998) due to non-compliance for some pharmaceutical
manufacturers, by brand name drug.

Merck

Zocor $986,250,000
Vasotec $600,000,000
Pepcid $277,500,000
Cozaar and Hyzaar $265,000,000
Fosamax $193,750,000
Mevacor $186,250,000
Prinivil $172,500,000

Pfizer

Norvasc $643,750,000
Lipitor $550,000,000
Zoloft $459,000,000
Zithromax $260,250,000
Procardia XL $178,500,000

Glaxo Welcome

Zantac $313,750,000
Imitrex $289,250,000
Flovent $206,325,000
Sereven $206,325,000
Zovirax $166,975,000

AstraZeneca

Prilosec / Losec $994,025,000
Zestril $280,500,000
Pulmicort $172,475,000
Tenormin $125,125,000

Novartis

Sandimmune & Neoral $319,000,000
Voltaren-XR $270,750,000
Lamisil $161,650,000
Lotensin $143,725,000

Bristo-Myers Squibb

Pravachol $410,750,000
Glucophage $215,250,000
Capoten $159,000,000
Zerit $137,750,000
BuSpar $132,750,000

Eli Lilly

Prozac $703,000,000
Zyprexa $360,750,000
Axid $104,500,000

Hoffmann La Roche

Rocephin $294,750,000
Accutane $139,775,000
Invirase $99,275,000

SmithKline Beecham

Paxil $439,250,000
Augmentin $399,500,000
Relafen $127,200,000

Johnson & Johnson

Propulsid $242,000,000
Risperdal $215,000,000

Schering Plough

Claritin $575,000,000
Vanceril DS $114,000,000
Proventil $66,250,000

Warner Lambert

Lipitor $550,000,000
Rezulin $187,000,000
Neurontin $128,500,000
Accupril $113,500,000

American Home Prod.

Effexor $132,250,000
Ativan $70,250,000
Cordarone $68,250,000

Hoechst

Cardizam $203,575,000
Allegra $121,175,000
Altace $109,400,000

Bayer

Cipro $350,750,000
Adalat $261,250,000
Precose $70,900,000


Total dollars lost due to noncompliance for these 57 products: $15,725,175,000
An average loss of $275,000,000 per product.



Contact:
Bart J. Zoltan
152 DeWolf Road
Old Tappan, NJ 07675
201 787-4415